ArcherDX scores $35 mln

Boulder, Colorado-based ArcherDX, a provider of NGS-based gene fusion detection assays, has secured $35 million in financing. Boulder Ventures Ltd and PBM Capital Group LLC led the round with participation from Longwood Fund and Peierls Foundation. In addition to the funding, Kyle Lefkoff of Boulder Ventures has joined ArcherDX’s board of directors.

Source: Press Release